Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06526884 · ClinicalTrials.gov registry record · NA
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
A NA study of Congestive Heart Failure and Pneumonia, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 1,080
- Enrollment target
- 1
- Study location
NCT06526884: Active NA study of Congestive Heart Failure and Pneumonia, sponsored by University of California, Los Angeles.
NCT06526884 is a NA study of Congestive Heart Failure and Pneumonia that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 1,080 participants, above the 309-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (250% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06526884, a NA study of Congestive Heart Failure and Pneumonia, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,080 participants
- Enrollment target
- 1
- Study location
Study Summary
The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.
Primary Outcome
Cumulative number of days alive and not admitted or boarding in a hospital or emergency department
Conditions Studied
Interventions
- OTHER Next Day Clinic
Study Locations (1)
California
- Ronald Reagan UCLA Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,080 participants |
| Start Date | 2024-07-22 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What the registry record for NCT06526884 still lists
NCT06526884 is an interventional study that assigns participants to a tested intervention. Its 1,080 participants enrollment target places it among the larger protocols in the corpus, above the 309-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (250% higher).
The record links to 8 conditions, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Next Day Clinic is the first listed.
NCT06526884 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06526884 about?
NCT06526884 is a clinical study titled "Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)". The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be...
What is the current status of trial NCT06526884?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,080 participants. The study started on 2024-07-22. Estimated completion is 2026-04-01.
What conditions does trial NCT06526884 study?
This clinical trial studies the following conditions: Congestive Heart Failure, Pneumonia, Syncope, Cellulitis, Diabetic Foot Infection.
What interventions are being tested in trial NCT06526884?
The interventions under investigation include: Next Day Clinic (OTHER).
Who is sponsoring clinical trial NCT06526884?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06526884 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06526884's enrollment target sits among peer trials
1,080 6th of 51 higher than 46 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
-
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI